927 jobs found in north carolina

As an Associate Neuroscience Specialty Representative, you will be responsible for:   Becoming knowledgeable of disease state, product and competitive market knowledge. Educating Healthcare providers on Vanda's product portfolio. Developing relationships with Healthcare providers in order to understand their needs. Education, Experience & Competencies Required: BS or BA in life science or business with GPA greater than 3.0. Interest and/or experience in healthcare field through internships, volunteer work, part-time jobs Excellent communication skills: interpersonal, verbal and written. Ability to learn, apply and communicate technical and scientific product- related information. Self-motivated, takes initiative and has an outstanding work ethic Interest in building negotiation and selling skills Seeking recent college graduates; candidates with limited prior work experience will also be considered. Pharmaceutical sales experience is not required.

At UCB, we put our heart, soul, and skills into making a difference for people living with severe disease. Working together to push the boundaries, we blend the best of our talents to unlock innovation. Will you join us in our pioneering adventure? UCB is a global biopharmaceutical company. We focus on discovering and developing innovative medicines and lateral solutions that can transform the everyday lives of people with severe diseases of the immune system – or the central nervous system. With more than 7500 people in approximately 40 countries, UCB offers an exciting working environment where initiative can flourish and those with a ‘can-do’ attitude can thrive. Scientific excellence, innovation, co-creation, lateral thinking, reinventing the way we do things…these are some of the key competencies we are constantly developing, and looking for, at UCB.

At UCB, we put our heart, soul, and skills into making a difference for people living with severe disease. Working together to push the boundaries, we blend the best of our talents to unlock innovation. Will you join us in our pioneering adventure? UCB is a global biopharmaceutical company. We focus on discovering and developing innovative medicines and lateral solutions that can transform the everyday lives of people with severe diseases of the immune system – or the central nervous system. With more than 7500 people in approximately 40 countries, UCB offers an exciting working environment where initiative can flourish and those with a ‘can-do’ attitude can thrive. Scientific excellence, innovation, co-creation, lateral thinking, reinventing the way we do things…these are some of the key competencies we are constantly developing, and looking for, at UCB.

At UCB, we put our heart, soul, and skills into making a difference for people living with severe disease. Working together to push the boundaries, we blend the best of our talents to unlock innovation. Will you join us in our pioneering adventure? UCB is a global biopharmaceutical company. We focus on discovering and developing innovative medicines and lateral solutions that can transform the everyday lives of people with severe diseases of the immune system – or the central nervous system. With more than 7500 people in approximately 40 countries, UCB offers an exciting working environment where initiative can flourish and those with a ‘can-do’ attitude can thrive. Scientific excellence, innovation, co-creation, lateral thinking, reinventing the way we do things…these are some of the key competencies we are constantly developing, and looking for, at UCB.

At UCB, we put our heart, soul, and skills into making a difference for people living with severe disease. Working together to push the boundaries, we blend the best of our talents to unlock innovation. Will you join us in our pioneering adventure? UCB is a global biopharmaceutical company. We focus on discovering and developing innovative medicines and lateral solutions that can transform the everyday lives of people with severe diseases of the immune system – or the central nervous system. With more than 7500 people in approximately 40 countries, UCB offers an exciting working environment where initiative can flourish and those with a ‘can-do’ attitude can thrive. Scientific excellence, innovation, co-creation, lateral thinking, reinventing the way we do things…these are some of the key competencies we are constantly developing, and looking for, at UCB.

At UCB, we put our heart, soul, and skills into making a difference for people living with severe disease. Working together to push the boundaries, we blend the best of our talents to unlock innovation. Will you join us in our pioneering adventure? UCB is a global biopharmaceutical company. We focus on discovering and developing innovative medicines and lateral solutions that can transform the everyday lives of people with severe diseases of the immune system – or the central nervous system. With more than 7500 people in approximately 40 countries, UCB offers an exciting working environment where initiative can flourish and those with a ‘can-do’ attitude can thrive. Scientific excellence, innovation, co-creation, lateral thinking, reinventing the way we do things…these are some of the key competencies we are constantly developing, and looking for, at UCB.

At UCB, we put our heart, soul, and skills into making a difference for people living with severe disease. Working together to push the boundaries, we blend the best of our talents to unlock innovation. Will you join us in our pioneering adventure? UCB is a global biopharmaceutical company. We focus on discovering and developing innovative medicines and lateral solutions that can transform the everyday lives of people with severe diseases of the immune system – or the central nervous system. With more than 7500 people in approximately 40 countries, UCB offers an exciting working environment where initiative can flourish and those with a ‘can-do’ attitude can thrive. Scientific excellence, innovation, co-creation, lateral thinking, reinventing the way we do things…these are some of the key competencies we are constantly developing, and looking for, at UCB.

At UCB, we put our heart, soul, and skills into making a difference for people living with severe disease. Working together to push the boundaries, we blend the best of our talents to unlock innovation. Will you join us in our pioneering adventure? UCB is a global biopharmaceutical company. We focus on discovering and developing innovative medicines and lateral solutions that can transform the everyday lives of people with severe diseases of the immune system – or the central nervous system. With more than 7500 people in approximately 40 countries, UCB offers an exciting working environment where initiative can flourish and those with a ‘can-do’ attitude can thrive. Scientific excellence, innovation, co-creation, lateral thinking, reinventing the way we do things…these are some of the key competencies we are constantly developing, and looking for, at UCB.

At UCB, we put our heart, soul, and skills into making a difference for people living with severe disease. Working together to push the boundaries, we blend the best of our talents to unlock innovation. Will you join us in our pioneering adventure? UCB is a global biopharmaceutical company. We focus on discovering and developing innovative medicines and lateral solutions that can transform the everyday lives of people with severe diseases of the immune system – or the central nervous system. With more than 7500 people in approximately 40 countries, UCB offers an exciting working environment where initiative can flourish and those with a ‘can-do’ attitude can thrive. Scientific excellence, innovation, co-creation, lateral thinking, reinventing the way we do things…these are some of the key competencies we are constantly developing, and looking for, at UCB.

At UCB, we put our heart, soul, and skills into making a difference for people living with severe disease. Working together to push the boundaries, we blend the best of our talents to unlock innovation. Will you join us in our pioneering adventure? UCB is a global biopharmaceutical company. We focus on discovering and developing innovative medicines and lateral solutions that can transform the everyday lives of people with severe diseases of the immune system – or the central nervous system. With more than 7500 people in approximately 40 countries, UCB offers an exciting working environment where initiative can flourish and those with a ‘can-do’ attitude can thrive. Scientific excellence, innovation, co-creation, lateral thinking, reinventing the way we do things…these are some of the key competencies we are constantly developing, and looking for, at UCB.

At UCB, we put our heart, soul, and skills into making a difference for people living with severe disease. Working together to push the boundaries, we blend the best of our talents to unlock innovation. Will you join us in our pioneering adventure? UCB is a global biopharmaceutical company. We focus on discovering and developing innovative medicines and lateral solutions that can transform the everyday lives of people with severe diseases of the immune system – or the central nervous system. With more than 7500 people in approximately 40 countries, UCB offers an exciting working environment where initiative can flourish and those with a ‘can-do’ attitude can thrive. Scientific excellence, innovation, co-creation, lateral thinking, reinventing the way we do things…these are some of the key competencies we are constantly developing, and looking for, at UCB.

At UCB, we put our heart, soul, and skills into making a difference for people living with severe disease. Working together to push the boundaries, we blend the best of our talents to unlock innovation. Will you join us in our pioneering adventure? UCB is a global biopharmaceutical company. We focus on discovering and developing innovative medicines and lateral solutions that can transform the everyday lives of people with severe diseases of the immune system – or the central nervous system. With more than 7500 people in approximately 40 countries, UCB offers an exciting working environment where initiative can flourish and those with a ‘can-do’ attitude can thrive. Scientific excellence, innovation, co-creation, lateral thinking, reinventing the way we do things…these are some of the key competencies we are constantly developing, and looking for, at UCB.

GENERAL RESPONSIBILITIES/DECISION MAKING AUTHORITY: Reports directly to the Regional Sales Manager. Develop and maintain strong working relationships with target HCPs. Deliver MLR approved, education-focused messages, as well as the assigned therapeutic area disease-state information to target HCPs. Business planning and execution. Enhance HCP awareness of Sun Ophthalmics products, clinical data, safety, and efficacy. Equip HCPs with appropriate tools to facilitate a robust conversation, enabling them to teach their patients about the assigned therapeutic area. Build HCP knowledge and confidence in identifying treatment gaps in all domains. Increase awareness of the assigned therapeutic area and help HCP identify treatment gaps in diagnosed patients. Metrics: Expected to achieve call activity and adherence targets; as well as financial goals for assigned territory. EDUCATION, EXPERIENCE & KNOWLEDGE: Minimum of a Bachelor’s degree required, preferably in a scientific field. Two or more years of pharmaceutical sales experience or equivalent are preferred. Two or more years of specialty pharmaceutical experience or equivalent, preferably in the assigned therapeutic area. Demonstrated knowledge and understanding of healthcare institutions and commercial managed care; experience selling within healthcare institutions preferred. Eye Care/Ophthalmology experience preferred.

At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 

At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 

At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 

At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 

At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 

At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives. 

At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP). We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.  Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.  Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.  We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.   Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.  Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.  Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders. Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability. We care deeply about making a difference. We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do. We are humbled by the opportunity to change lives.